FDA Adverse Event Injury Summary report: N

SERI SURGICAL SCAFFOLD (US)

MDR report key: 4223537 · Received October 29, 2014

Report

Report Number
3008374097-2014-00109
Event Type
Injury
Date Received
October 29, 2014
Date of Event
September 23, 2014
Report Date
October 1, 2014
Manufacturer
ALLERGAN
Product Code
OXF
PMA / PMN Number
K123128
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

FURTHER INFO FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFO IS AVAILABLE AT THIS TIME. THE EVENT OF INFECTION IS A PHYSIOLOGICAL COMPLICATION, AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. DEVICE LABELING ADDRESSES THE REPORTED EVENT OF INFECTION AS FOLLOWS: ADVERSE REACTIONS ARE THOSE TYPICALLY ASSOCIATED WITH SURGICALLY IMPLANTABLE MATERIALS, INCLUDING INFECTION, INFLAMMATION, ADHESION FORMATION, FISTULA FORMATION, AND EXTRUSION. THIS EVENT IS BEING REPORTED BECAUSE MED INTERVENTION WAS REQUIRED, ALTHOUGH DEVICE RELATEDNESS HAS NOT BEEN ESTABLISHED.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED IMPLANTATION OF SERI ON (B)(6) 2014 DURING BILATERAL BREAST LIFT SURGERY. POST-IMPLANTATION ON (B)(6) 2014, PT PRESENTED WITH FLUID AND REDNESS IN THE RIGHT BREAST. A DIAGNOSTIC CULTURE RESULTED IN STAPHYLOCOCCUS AUREUS GROWTH. TREATMENT INCLUDED ASPIRATION OF THE FLUID AND ANTIBIOTICS. DEVICE REMAINS IMPLANTED AND IS UNAVAILABLE FOR RETURN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
692716 SERI SURGICAL SCAFFOLD (US) OXF ALLERGAN NA P13082701A

Patients

Seq Age Sex Outcome Treatment
1 45 YR Required Intervention